Mobile harm-reduction care for women who use drugs in Baltimore
Implementing and evaluating the impact of novel mobile harm reduction services on overdose among women who use drugs: The SHOUT study.
This project brings mobile harm-reduction services to women who use drugs in Baltimore to reduce overdoses and connect them with medical and support services.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11364694 on NIH RePORTER |
What this research studies
If I join, outreach teams will bring low-barrier mobile services directly into Baltimore neighborhoods, offering naloxone, safer use supplies, individual counseling, and help linking to HIV, HCV, and other care. The project will enroll about 400 women who use drugs and follow them over time to track nonfatal overdoses and engagement with clinical services. The researchers use a hybrid effectiveness-implementation approach to measure both health outcomes and how well the mobile program is delivered in new neighborhoods. The team will focus on services tailored to women's needs and document barriers and facilitators to reaching people where they are.
Who could benefit from this research
Good fit: Ideal candidates are adult women who use drugs and live in Baltimore City or County neighborhoods served by the Mobile SPARC outreach program.
Not a fit: People who do not use drugs, live outside the targeted Baltimore City/County area, or already have stable, comprehensive harm-reduction and treatment services are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this could reduce nonfatal overdoses among women who use drugs and increase their access to HIV, HCV, and other healthcare services.
How similar studies have performed: Other mobile harm-reduction and naloxone distribution programs have shown benefits in reducing overdoses, but a women-centered mobile model like this is relatively novel.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sherman, Susan G. — Johns Hopkins University
- Study coordinator: Sherman, Susan G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.